Epidermal Growth Factor Receptor Inhibitor Therapy for Recurrent Respiratory Papillomatosis

F1000Research - United Kingdom
doi 10.12688/f1000research.2-202.v1
Full Text
Abstract

Available in full text

Date
Authors
Publisher

F1000 Research Ltd

Related search

Recurrent Respiratory Papillomatosis

2020English

Recurrent Respiratory Papillomatosis

Radiographics
MedicineNuclear MedicineRadiologyImaging
2018English

Anti-Epidermal Growth Factor Receptor Gene Therapy for Glioblastoma

PLoS ONE
Multidisciplinary
2016English

83 Recurrent Respiratory Papillomatosis

2018English

Nursing Management of Epidermal Growth Factor Receptor Inhibitor-Induced Toxicities

Clinical Journal of Oncology Nursing
Oncology
2008English

The Epidermal Growth Factor Receptor Pathway: A Model for Targeted Therapy

Clinical Cancer Research
Cancer ResearchOncology
2006English

Recurrent Respiratory Papillomatosis (RRP)—Juvenile Onset

Clinical medicine. Oncology
2008English

Improving Therapy for Patients With Epidermal Growth Factor Receptor-Mutant Lung Cancer

Cancer
Cancer ResearchOncology
2018English

Epidermal Growth Factor Receptor and Human Epidermal Growth Receptor 2 Expression in Parotid Mucoepidermoid Carcinoma: Possible Implications for Targeted Therapy

Oncology Reports
MedicineCancer ResearchOncology
2008English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy